Skip to content

Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan

Clinical Evaluation of Opti-Free III Compared to Opti-Free Plus®

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02251561
Enrollment
36
Registered
2014-09-29
Start date
2013-11-30
Completion date
2014-05-31
Last updated
2015-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Staining

Keywords

contact lenses, contact lens solution, corneal staining, fluorescein

Brief summary

The purpose of this study is to compare an investigational contact lens care product (FID 109182) to a commercially available contact lens product (Opti-Free Plus®) for corneal staining when used with Acuvue® Oasys® contact lenses. The contact lenses will be pre-soaked in the products for 24-48 hours prior to a 2-hour contralateral wear period.

Interventions

DEVICEFID 109182

Investigational multipurpose contact lens cleaning and disinfecting solution

DEVICEOpti-Free Plus

Commercially available multipurpose contact lens cleaning and disinfecting solution

Commercially available silicone hydrogel contact lens

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Soft contact lenses habitual wearer, both eyes. * Voluntarily sign Informed Consent. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Unable to tolerate the ingredients in Opti-Free® and similar contact lens care products. * Potential use of eye drops during the study, including over-the-counter products, except for artificial tear eye drops. * Eye infection, blepharitis, iris inflammation, or severe eye inflammation. * Corneal staining greater than Grade 1 at baseline. * Pregnant, lactating, or intend to become pregnant during study period. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Participants Scoring ≥ 2 for Corneal Staining Density With FluoresceinDay 1, after 2 hours of wearThe contact lens was removed, the cornea was stained with fluorescein (ophthalmic dye), and pictures of the corneal surface were taken. Corneal staining density was evaluated for each eye individually against representative pictures and scored on a 0-3 scale (0=No staining; 1=Staining with low density; 2=Staining with moderate density; 3=Staining with severe density). Proportion of participants is reported as a percentage.

Secondary

MeasureTime frameDescription
Proportion of Participants Scoring ≥ 2 for Corneal Staining Area With FluoresceinDay 1, after 2 hours of wearThe contact lens was removed, the cornea was stained with fluorescein (ophthalmic dye), and pictures of the corneal surface were taken. Corneal staining area was evaluated for each eye individually against representative pictures and scored on a 0-3 scale \[0=No staining; 1=Staining with small area (1 to 25% of corneal surface); 2=Staining with medium area (26 to 50% of corneal surface); 3=Staining with large area (51% of corneal surface or greater)\]. Proportion of participants is reported as a percentage.

Participant flow

Recruitment details

Subjects were enrolled from one study site located in Japan.

Pre-assignment details

Of the 36 subjects enrolled in the study, 8 were exited prior to product exposure \[did not meet eligibility criteria (5), and subject withdrawal (3)\]. This reporting group includes all subjects who used the study products (28).

Participants by arm

ArmCount
FID 109182/Opti-Free Plus
Senofilcon A contact lens pre-soaked in FID 109182 in 1 eye, with senofilcon A contact lens pre-soaked in Opti-Free Plus in the fellow eye. Lenses worn contralaterally for 2 hours.
28
Total28

Baseline characteristics

CharacteristicFID 109182/Opti-Free Plus
Age, Continuous28.0 years
STANDARD_DEVIATION 7.5
Region of Enrollment
Japan
28 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 280 / 28
serious
Total, serious adverse events
0 / 280 / 28

Outcome results

Primary

Proportion of Participants Scoring ≥ 2 for Corneal Staining Density With Fluorescein

The contact lens was removed, the cornea was stained with fluorescein (ophthalmic dye), and pictures of the corneal surface were taken. Corneal staining density was evaluated for each eye individually against representative pictures and scored on a 0-3 scale (0=No staining; 1=Staining with low density; 2=Staining with moderate density; 3=Staining with severe density). Proportion of participants is reported as a percentage.

Time frame: Day 1, after 2 hours of wear

Population: This analysis population includes all subjects who used the study products and had examination/observation data after use.

ArmMeasureValue (NUMBER)
FID 109182Proportion of Participants Scoring ≥ 2 for Corneal Staining Density With Fluorescein92.6 percentage of participants
Opti-Free PlusProportion of Participants Scoring ≥ 2 for Corneal Staining Density With Fluorescein22.2 percentage of participants
Secondary

Proportion of Participants Scoring ≥ 2 for Corneal Staining Area With Fluorescein

The contact lens was removed, the cornea was stained with fluorescein (ophthalmic dye), and pictures of the corneal surface were taken. Corneal staining area was evaluated for each eye individually against representative pictures and scored on a 0-3 scale \[0=No staining; 1=Staining with small area (1 to 25% of corneal surface); 2=Staining with medium area (26 to 50% of corneal surface); 3=Staining with large area (51% of corneal surface or greater)\]. Proportion of participants is reported as a percentage.

Time frame: Day 1, after 2 hours of wear

Population: This analysis population includes all subjects who used the study products and had examination/observation data after use.

ArmMeasureValue (NUMBER)
FID 109182Proportion of Participants Scoring ≥ 2 for Corneal Staining Area With Fluorescein92.6 percentage of participants
Opti-Free PlusProportion of Participants Scoring ≥ 2 for Corneal Staining Area With Fluorescein44.4 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026